Risk of Adverse Outcomes Linked with Acute Declines in Estimated GFR During RAS Inhibition
The following is a summary of “Association between Acute Declines in eGFR during Renin-Angiotensin System Inhibition and Risk of Adverse Outcomes,” published in the June 20204 issue of Nephrology by Ku et al. The initiation of the renin-angiotensin system (RAS) has...